• Science & Technology
• Health & Medicine

Blood test tracks breast cancer

13 March 2013

• Health & Medicine

Chemo given into the abdomen could boost ovarian cancer survival

Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer. Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer.

6 March 2013

• Health & Medicine

Docetaxel significantly increases survival for incurable gastric cancers

Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today. Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today.

23 January 2013

• Health & Medicine

Clinical trials: Helping more children beat cancer every year

During childhood cancer awareness month we focus on how clinical trials are a vital part of helping children beat cancer. During childhood cancer awareness month we focus on how clinical trials are a vital part of helping children beat cancer.

18 December 2012

• Health & Medicine

Expert opinion: Professor Dion Morton - combining chemo and surgery in colon cancer

3 December 2012

• Health & Medicine

Bowel cancer 'chemo swap' shrinks tumours, making surgery safer and easier

Giving some bowel cancer patients six weeks of chemotherapy before surgery can significantly shrink their tumour, making it easier to remove and potentially reducing the chances of the cancer coming back, according to results from a major Cancer Research UK-funded pilot study published this month in Lancet Oncology. Giving some bowel cancer patients six weeks of chemotherapy before surgery can significantly shrink their tumour, making it easier to remove and potentially reducing the chances of the cancer coming back, according to results from a major Cancer Research UK-funded pilot study published this month in Lancet Oncology.

1 November 2012

• Health & Medicine

Anti-alcoholism drug could help treat most common type of adult brain cancer

A drug that has been used to treat alcoholic patients for more than sixty years could potentially help treat glioblastoma. A drug that has been used to treat alcoholic patients for more than sixty years could potentially help treat glioblastoma.

24 October 2012

• Health & Medicine

New trial will investigate cancer-fighting properties of chemical related to cannabis

Chemicals similar to those found in cannabis form the basis of a new drug that is being trialled in UK cancer patients for the first time by researchers at the Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre in Newcastle. Chemicals similar to those found in cannabis form the basis of a new drug that is being trialled in UK cancer patients for the first time by researchers at the Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre in Newcastle.

28 September 2012

• Science & Technology
• Health & Medicine

Gene helps predict which women with ovarian cancer will benefit most from chemotherapy

Measuring how active a gene is in women with ovarian cancer could predict who will benefit from platinum-based chemotherapy drugs – a common treatment for the disease. Measuring how active a gene is in women with ovarian cancer could predict who will benefit from platinum-based chemotherapy drugs – a common treatment for the disease.

19 September 2012

• Health & Medicine

Headlines about ‘backfiring’ chemotherapy are misleading

6 August 2012

• Health & Medicine

Cancer Research UK launches trial of experimental drug combination for advanced stomach and oesophageal cancer

Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer. Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer.

8 June 2012

• Health & Medicine

New trial to test spice extract curcumin against bowel cancer

7 May 2012